Related Experiment Videos
Experimental study of the pathogenesis of infantile obstructive cholangiopathy and its clinical evaluation
Insights
Exposure to 1,4-phenylenediisothiocyanate in rats at different developmental stages revealed distinct hepatobiliary system changes. This study models infantile obstructive cholangiopathy, suggesting developmental timing influences pathology and biliary atresia outcomes.
Area of Science:
- Toxicology
- Developmental Biology
- Hepatology
Background:
- Infantile obstructive cholangiopathy encompasses conditions like biliary atresia and neonatal hepatitis.
- The precise pathogenic mechanisms and developmental influences are not fully understood.
- 1,4-phenylenediisothiocyanate is a chemical agent used to induce experimental toxic effects.
Purpose of the Study:
- To investigate the histopathological changes in the hepatobiliary system of rats exposed to 1,4-phenylenediisothiocyanate at various developmental stages.
- To establish an experimental model for infantile obstructive cholangiopathy.
- To explore the relationship between developmental timing of exposure and observed pathologies, including biliary atresia.
Main Methods:
- Five groups of rats (n=97) at different developmental stages were administered 1,4-phenylenediisothiocyanate.
- Histopathological examination of the hepatobiliary system was performed.
- Comparison of pathological features, including extrahepatic bile duct changes, inflammation, stenosis, atresia, thickening, and fibrosis.
- Analysis of cases of correctable versus non-correctable biliary atresia.
Main Results:
- Rats exposed postnatally showed dilated extrahepatic bile ducts with inflammation.
- Rats exposed during the fetal period or postnatally exhibited stenotic or atretic extrahepatic bile ducts due to wall thickening and fibrosis.
- The study suggests that the timing of 1,4-phenylenediisothiocyanate exposure influences the type and severity of hepatobiliary pathology.
- Comparison of biliary atresia cases indicated potential differences in pathogenic process timing between correctable and non-correctable types.
Conclusions:
- The developmental stage at which 1,4-phenylenediisothiocyanate exposure occurs significantly impacts the resulting hepatobiliary pathology.
- This experimental model provides insights into the varied pathologies observed in infantile obstructive cholangiopathy.
- The findings suggest that the timing of the pathogenic process during development may differentiate between correctable and non-correctable forms of biliary atresia.
Abstract:
1,4-phenylenediisothiocyanate was given to five groups of rats of different developmental stages (97 in all), and the changes in the hepatobiliary system were compared histopathologically. Three groups of rats given the drug after birth showed dilatation of the extrahepatic bile ducts with inflammation. Two groups given the drug during the fetal period or added after birth showed stenotic or atretic extrahepatic bile ducts due to thickening and fibrosis of the wall. This experimental model suggests that differences in the pathologic features of infantile obstructive cholangiopathy (biliary atresia, neonatal hepatitis, and bile duct dilatation) may be the result of various developmental stages in the pathogenic process. After the experiment, 11 cases of correctable type biliary atresia were compared to 24 cases of noncorrectable type in various aspects. It is suggested that the correctable type may have suffered pathogenic process later in the developmental stages than noncorrectable type.